IP Library Granted Patent US 9,125,814
Granted Patent B2
US 9,125,814 · App. 12/428,411 · Granted Sep 8, 2015

Biocompatible crosslinked hydrogels, drug-loaded hydrogels and methods of using the same

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,125,814
App. No.
12/428,411
Granted
Sep 8, 2015
Kind
B2
Abstract

Disclosed are hydrogel compositions formed by the mixture of a tetramethylmethane substituted with one or more polyethylene glycols, and wherein each polyethylene glycol substituent is independently further substituted with one or more electrophilic groups, and a tetramethylmethane substituted with one or more polyethylene glycols, and wherein each polyethylene glycol substituent is independently further substituted with one or more nucleophilic groups. Disclosed are also methods of preparing the above hydrogels. The hydrogel compositions can further comprise pharmaceuticals, such as analgesics or local anesthetics. Disclosed are also methods of sealing a wound, preventing post-surgical adhesion, and reducing post-surgical pain using the disclosed hydrogels.

Claims (28)

1. A composition comprising a biocompatible hydrogel and an analgesic, wherein the analgesic is uniformly distributed in the hydrogel as in situ generated particles, and wherein the biocompatible hydrogel is produced by a method comprising:

mixing a first compound and a second compound to obtain a first mixture,

adding an acidic aqueous solution and the analgesic to the first mixture to obtain a first solution,

adding a basic aqueous solution to the first solution, wherein,

the first compound is a compound of Formula I:

wherein

each R 1 is independently selected from the group consisting of hydrogen, alkyl, —C(═O)R 3 , and —C(═O)OR 3 ;

each R 2 is independently selected from the group consisting hydrogen, alkyl, and —(CH 2 CH 2 O) n —R 4 ,

R 3 is selected from the group consisting of hydrogen, halogen, amino, monoalkylamino, dialkylamino, alkyl, carbocyclyl, and heterocyclyl;

each R 4 is independently selected from the group consisting hydrogen, alkyl, —CH 2 CH 2 OH, and —CH 2 CH 2 OR 1 ;

each n is independently an integer greater than 1;

wherein at least one of R 1 is not hydrogen or alkyl; and

the second compound is a compound of Formula III:

wherein

each R 5 is independently selected from the group consisting of hydrogen, alkyl, —OR 7 , —SR 7 , and —N(R 7 ) 2 ;

each R 6 is independently selected from the group consisting hydrogen, alkyl, and —(CH 2 CH 2 O) n —R 8 ;

each R 7 is independently selected from the group consisting of hydrogen, alkyl, carbocyclyl, and heterocyclyl;

each R 8 is independently selected from the group consisting hydrogen, alkyl, and —CH 2 CH 2 R 5 ;

each n is independently an integer greater than 1;

wherein at least one of —R 5 is not hydrogen or alkyl, and

wherein the analgesic is a local anesthetic selected from the group consisting of bupivacaine, levobupivacaine, ropivacaine, lidocaine, mepivacaine, prilocaine, cinchocaine, etidocaine, articaine and salts thereof.

2. The composition of claim 1 , wherein the compound of Formula I is a compound of Formula I.2:

wherein at least one of —OR 1 is

3. The composition of claim 1 , wherein the compound of Formula I is a compound of Formula II.3:

wherein each n is independently an integer greater than 1.

4. The composition of claim 1 , wherein the compound of Formula III is a compound of Formula IV.1, Formula IV.2 Formula IV.3, Formula IV.4 or Formula IV.5:

wherein each n is independently an integer greater than 1.

5. The composition of claim 1 , wherein the particles of the analgesic are 1 -50 microns in sizes.

Assignments (13)
RELEASE OF SECURITY INTEREST : RECORDED AT REEL/FRAME - 049288/0184 Recorded Jan 29, 2021
From: CAPITAL ONE, NATIONAL ASSOCIATION
To: ANGIOTECH PHARMACEUTICALS, INC.
Reel/Frame 055171/0634 →
SECURITY INTEREST Recorded May 26, 2019
From: ANGIOTECH PHARMACEUTICALS, INC.
To: CAPITAL ONE, NATIONAL ASSOCIATION, AS ADMINISTRATIVE AGENT
Reel/Frame 049288/0184 →
RELEASE OF SECURITY INTEREST Recorded May 7, 2019
From: VIRTUS GROUP, LP, AS ADMINISTRATIVE AGENT FOR THE LENDERS
To: SURGICAL SPECIALTIES CORPORATION LIMITED
Reel/Frame 049106/0173 →
CORRECTIVE ASSIGNMENT TO CORRECT THE ASSIGNEE ADDRESS PREVIOUSLY RECORDED ON REEL 042115 FRAME 0140. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT. Recorded Aug 8, 2017
From: ANGIOTECH PHARMACEUTICALS, INC.
To: SURGICAL SPECIALTIES CORPORATION LIMITED
Reel/Frame 043332/0360 →
PARTIAL RELEASE OF SECURITY INTEREST Recorded Apr 5, 2017
From: VIRTUS GROUP, LP
To: ANGIOTECH PHARMACEUTICALS, INC.
Reel/Frame 042166/0029 →
SECURITY INTEREST Recorded Apr 5, 2017
From: SURGICAL SPECIALTIES CORPORATION LIMITED
To: VIRTUS GROUP, LP
Reel/Frame 041860/0980 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 28, 2017
From: ANGIOTECH PHARMACEUTICALS, INC.
To: SURGICAL SPECIALTIES CORPORATION LIMITED
Reel/Frame 042115/0140 →
SECURITY INTEREST Recorded Mar 10, 2017
From: ANGIOTECH PHARMACEUTICALS, INC.
To: VIRTUS GROUP, LP
Reel/Frame 041539/0864 →
RELEASE OF SECURITY INTEREST Recorded Apr 15, 2013
From: DEUTSCHE BANK NATIONAL TRUST COMPANY
To: ANGIOTECH PHARMACEUTICALS, INC.; AMERICAN MEDICAL INSTRUMENTS HOLDINGS, INC.; ANGIOTECH AMERICA, INC.; ANGIOTECH BIOCOATINGS CORP.; ANGIOTECH PHARMACEUTICALS (US), INC.; B.G. SULZLE, INC.; MANAN MEDICAL PRODUCTS, INC.; MEDICAL DEVICE TECHNOLOGIES, INC.; QUILL MEDICAL, INC.; SURGICAL SPECIALTIES CORPORATION; ANGIOTECH INTERNATIONAL HOLDINGS CORP.
Reel/Frame 030218/0820 →
RELEASE OF SECURITY INTEREST Recorded Apr 12, 2013
From: WELLS FARGO CAPITAL FINANCE, LLC
To: ANGIOTECH PHARMACEUTICALS, INC.; AMERICAN MEDICAL INSTRUMENTS HOLDINGS, INC.; ANGIOTECH AMERICA, INC.; ANGIOTECH BIOCOATINGS CORP.; ANGIOTECH PHARMACEUTICALS (US), INC.; B.G. SULZLE, INC.; MANAN MEDICAL PRODUCTS, INC.; MEDICAL DEVICE TECHNOLOGIES, INC.; QUILL MEDICAL, INC.; SURGICAL SPECIALTIES CORPORATION; ANGIOTECH INTERNATIONAL HOLDINGS CORP.
Reel/Frame 030211/0479 →
PATENT SECURITY AGREEMENT Recorded May 13, 2011
From: ANGIOTECH PHARMACEUTICALS, INC.; AFMEDICA, INC.; AMERICAN MEDICAL INSTRUMENTS HOLDINGS, INC.; ANGIOTECH AMERICA, INC.; ANGIOTECH BIOCOATINGS CORP.; ANGIOTECH DELAWARE, INC.; ANGIOTECH FLORIDA HOLDINGS, INC.; ANGIOTECH PHARMACEUTICALS (US), INC.; B.G. SULZLE, INC.; MANAN MEDICAL PRODUCTS, INC.; MEDICAL DEVICE TECHNOLOGIES, INC.; NEUCOLL INC.; QUILL MEDICAL, INC.; SURGICAL SPECIALTIES CORPORATION; 0741693 BRITISH COLUMBIA LTD.; ANGIOTECH INTERNATIONAL HOLDINGS, CORP.
To: WELLS FARGO CAPITAL FINANCE, LLC, AS ADMINISTRATIVE AGENT
Reel/Frame 026275/0507 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 9, 2009
From: HE, YUEHUA; TAKACS-COX, ANIKO; BOEY, ANTHONY; ZALUSKI, BRENT; SMITH, ROGER A.; DESCHAMPS, AUDREY A.; AVELAR, RUI
To: ANGIOTECH PHARMACEUTICALS, INC.
Reel/Frame 023205/0222 →
SECURITY AGREEMENT Recorded May 1, 2009
From: ANGIOTECH PHARMACEUTICALS, INC.; AFMEDICA, INC.; AMERICAN MEDICAL INSTRUMENTS HOLDINGS, INC.; ANGIOTECH AMERICA, INC.; ANGIOTECH BIOCOATINGS CORP.; ANGIOTECH CAPITAL, LLC; ANGIOTECH PHARMACEUTICALS (US), INC.; B.G. SULZLE, INC.; CRIMSON CARDINAL CAPITAL, LLC; MANAN MEDICAL PRODUCTS, INC.; MEDICAL DEVICE TECHNOLOGIES, INC.; NEUCOLL, INC.; QUILL MEDICAL, INC.; SURGICAL SPECIALTIES CORPORATION; 0741693 B.C. LTD.; 3091796 NOVA SCOTIA COMPANY; ANGIOTECH INTERNATIONAL HOLDINGS, CORP.; ANGIOTECH INVESTMENT PARTNERSHIP
To: WELLS FARGO FOOTHILL, LLC, AS AGENT
Reel/Frame 022624/0698 →